Human lactate dehydrogenase a inhibitors: a molecular dynamics investigation
- PMID: 24466056
- PMCID: PMC3895040
- DOI: 10.1371/journal.pone.0086365
Human lactate dehydrogenase a inhibitors: a molecular dynamics investigation
Abstract
Lactate dehydrogenase A (LDHA) is an important enzyme in fermentative glycolysis, generating most energy for cancer cells that rely on anaerobic respiration even under normal oxygen concentrations. This renders LDHA a promising molecular target for the treatment of various cancers. Several efforts have been made recently to develop LDHA inhibitors with nanomolar inhibition and cellular activity, some of which have been studied in complex with the enzyme by X-ray crystallography. In this work, we present a molecular dynamics (MD) study of the binding interactions of selected ligands with human LDHA. Conventional MD simulations demonstrate different binding dynamics of inhibitors with similar binding affinities, whereas steered MD simulations yield discrimination of selected LDHA inhibitors with qualitative correlation between the in silico unbinding difficulty and the experimental binding strength. Further, our results have been used to clarify ambiguities in the binding modes of two well-known LDHA inhibitors.
Conflict of interest statement
Figures










References
-
- Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646–674. - PubMed
-
- Warburg O (1956) On respiratory impairment in cancer cells. Science 124: 269–270. - PubMed
-
- Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891–899. - PubMed
-
- Banga I, Szent-Gyorgyi A, Vargha L (1932) The coenzyme of lactic acid oxidation. Hoppe Seylers Z Physiol Chem 210: 228–235.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous